Related Experiment Video
Updated: Jul 5, 2026

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
Published on: October 6, 2023
[Three case-reports of viperin envenoming in Morocco]
M Chani1, H L'kassimi, A Abouzahir
1Service des urgences, hôpital militaire Moulay-Ismail, Mekhnès et Clinique-Royale, Rabat, Maroc. chani.mohamed@caramail.com
Abstract:
Snake bites are responsible for a high mortality rate in Africa. Problems for the early care of the victims are many. We published three observations of Moroccan typical viperin severe envenomings (rapidly extensive edema, necrosis, haemorrhagic shock) are presented. The overall mortality of those bites is 4%. In the Maghreb, viperin syndromes are the result of the lebetin viper (Vipera lebetina), the horned viper or sand viper (Cerastes cerastes), sometimes Bitis or Echis sp. Immunotherapy remains effective against haemorrhage, even when administered late, in severe disease (bleeding). Death remains inevitable if antivenin is not being administered or if it is at the stage of multiorgan failure. Heparin is contra-indicated in the acute context, but at distance from the bite, the persistence of inflammatory syndrome can cause phlebitis or pulmonary embolism. Fresh frozen plasma and corticosteroids are ineffective and unnecessary. Signs of gravity are rapidly extensive swelling and systemic manifestations, particularly bleeding. The severity of poisoning is related to the difficulties of access to health centers, the use of traditional medicine for more than half of the victims, the lack of training of caregivers, finally and most importantly, the lack of antivenomous serum,that is not within reach of prescribing at the appropriate places and times. Despite its cost and allergic risk (become rare with the current serums), immunotherapy which is the only weapon effective against the venom, should be part of emergency essential drugs.
Insights
Snake bites in Africa cause high mortality due to delayed care and lack of antivenomous serum. Early immunotherapy is crucial for treating severe viper envenomings and preventing fatalities.
Area of Science:
- Toxicology
- Emergency Medicine
- Herpetology
Background:
- Snake bites represent a significant public health issue in Africa, leading to high mortality rates.
- Early management of snakebite victims is often hindered by numerous challenges, impacting patient outcomes.
Observation:
- Three cases of severe Moroccan viper envenomings (Vipera lebetina, Cerastes cerastes) are presented, characterized by rapid edema, necrosis, and hemorrhagic shock.
- The overall mortality rate for these specific viper bites was observed to be 4%.
Findings:
- Immunotherapy remains effective against venom-induced hemorrhage, even when administered late in severe cases.
- Antivenom administration is critical; death is inevitable without it or if multiorgan failure occurs.
- Heparin is contraindicated in acute snakebite, while fresh frozen plasma and corticosteroids are ineffective.
Implications:
- The severity of snakebite poisoning is exacerbated by limited healthcare access, reliance on traditional medicine, inadequate caregiver training, and critical shortages of antivenomous serum.
- Despite cost and allergy risks, immunotherapy is the only effective treatment and should be prioritized as an essential emergency drug.
More Related Videos
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Treatment Strategies
Physical Properties of Amines
Rocky Mountain Spotted Fever

